Abstract
Results from several medical investigations carried out using the Oxford scanning proton microprobe are presented, including maps of the hepatic copper-distribution in primary biliary cirrhosis and maps of the iron distribution in primary hemochromatosis. Preliminary studies of human nervous tissue reveal that morphologically recognizable structures can be differentiated using precision elemental mapping, and this may lead to a powerful new way of distinguishing subtle perturbations of structure and function. In further prelimianry studies, localized aluminum structures have been observed in Alzheimer’s disease tissue at bulk levels of less than parts per million.
Similar content being viewed by others
References
C. R. Fleminget al. (1974)Gastroenterology 67, 1182–1187.
G. Deconnick, F. Bodart, and E. Demonlin (1981)Nucl. Instrum. Methods 181, 250–263.
R. A. Smallwood, H. A. Williams, V. M. Rosenoer (1968)Lancet ii, 1310–1313.
W. Maenhautet al. (1981)Nucl. Sci. 28, 1386–1394.
T. B. Johanssonet al. (1970)Nucl. Instrum. Methods 84, 141.
J. A. Cookson and F. D. Pilling (1970)Thin Solid Films 19, 381.
J. A. Cooksonet al. (1972)J. Radioanal. Chem. 12, 39.
S. A. E. Johansson and T. B. Johansson (1976)Nucl. Instrum. Methods 137, 473–485.
F. Wattet al. (1982)Nucl. Instrum. Methods 197, 65–77.
“First International Workshop on Applications of Nuclear Analytical Techniques” Brookhaven 1983, inNeurotoxicology 4, 3.
P. P. Anthonyet al. (1978)J. Clin. Path. 31, 395–415.
A. H. Huntet al. (1963)br. Med. J. 2, 1489–1501.
C. R. Fleminget al. (1974)Gastroenterology 67, 1182–1187.
O. Epsteinet al. (1981)J. Clin. Pathol. 34, 1071–1075.
S. Goldfischer and I. Sternlieb (1968)Am. J. Pathol. 53, 883–895.
L. L. Uzman (1956)Lab. Invest. 5, 299–305.
S. Goldfischeret al. (1980)Am. J. Pathol. 99, 715–730.
D. J. T. Vauxet al. (1985)J. Clin. Path. 38, 653–658.
G. W. Grime, J. Takacs, and F. Watt (1984)Nucl. Instrum. Methods B3, 589–593.
G. W. Grime and F. Watt (1983) “Beam optics of quadrupole probe forming systems” Adam Hilger, Bristol.
J. Kagiet al. Nature 292, 495–496.
R. H. Buhler and J. Kagi (1974)FEBS Letts. 39, 229–234.
R. W. Briggs and I. M. Armitage (1982)J. Biol. Chem. 257, 1259–1262.
L. Ryden and H. F. Deutsch (1978)J. Biol. Chem. 253, 519–524.
J. R. Riordan and V. Richards (1980)J. Biol. Chem. 255, 5380–5383.
S. Sherlock (1982)Lancet i, 782–786.
D. K. Dastur and D. K. Manghani (1967)Ind. J. Pathol. Bacteriol. 10, 177–183.
J. Evanset al. (1980)Gut 21, 970–976.
S. Jainet al. (1978)J. Clin. Pathol. 31, 784–790.
A. Trousseau (1865)Clin. Med. L’Hotel Dieu Paris 2, 663–698.
M. Troisier (1871)Bull. Soc. Anat. Paris 44, 231–235.
F. D. Von Recklinghausen (1889) Uber Hämochromatose, inTagebl. der Versamml. Deutsche Natur und Arzte Heidelberg, pp. 324–325.
J. H. Sheldon (1927)Quant. J. Med. 21, 123–137.
J. H. Sheldon (1935)Haemochromatosis Oxford University.
R. Saddi and J. Feingold (1974)Clin. Genet. 5, 242–247.
M. Simonet al. (1975) Haemochromatose idiopathique: maladie associee a l’antigene tissulaire HLA-A3?”.Nouv. Presse Med,4, 1432–38.
W. G. Shewanet al. (1976)Brit. Med. J. i, 281–282.
M. H. Bremminget al. (1977)Hum. Genet. 37, 131–139.
C. Q. Edwardset al. (1980)Hum. Immunol. 1, 19–22.
G. O. Walterset al. (1975)Gut 16, 188–192.
R. Greenet al. (1968)Am. J. Med. 45, 336–353.
M. L. Bassettet al. (1979)Lancet ii, 4–7.
M. M. Dadoneet al. (1982)Am. J. Clin. Pathol. 78, 196–207.
U. Lindh (1982)Nucl. Instrum. Methods 193, 343–347.
E. B. Ilgrenet al. (1984)J. Neurosci. Meth. 12, 25–28.
R. R. Bailey (1972)Lancet ii, 276–277.
A. I. G. McLaughlinet al. (1962)Br. J. Indust. Med. 19, 253–263.
A. C. Alfreyet al. (1976)New Engl. J. Med. 294, 184–188.
J. R. McDermottet al. (1978)Lancet i, 901–904.
J. R. McDermottet al. (1977)Lancet ii, 710–711.
W. R. Markesburyet al. (1981)Ann. Neurol. 10, 511–516.
L. W. Sequieraet al. (1979)Lancet ii, 609–612.
G. Acieruo and A. R. Massaro (1981)Gerontology 27, 100.
C. Wikkelsoet al. (1981)J. Neurol. Sci. 49, 293–303.
D. R. Crapperet al. (1976)Brain 99, 67–80.
R. D. Terry and C. Pena (1965)J. Neuropathol. Exp. Neurol. 2, 200–210.
L. Klatzoet al. (1965)J. Neuropathol. Exp. Neurol. 24, 187–190.
K. S. Kosilket al. (1983)J. Neuropathol. Exp. Neurol. 42, 365–375.
E. K. Perryet al. (1978)Brit. Med. J. ii, 1457–1459.
G. K. Wilcocket al. (1983)Neuropathol. Applied Neurobiol. 9, 175–179.
I. Janota (1981) “Pathology of Dementia” Ch. 4, inRecent Advances in Histopathology.
H. M. Wisniewski (1980) Neurofibrillary and synaptic pathology in senile dementia of the Alzheimer type, inAlzheimer’s disease, A. I. M. Glen and L. J. Whalley, eds., Churchill Livingstone.
G. Blessedet al. (1968)Br. J. Psych. 114, 797–811.
D. G. Fraseret al. (1984)Nature 312, 352–354.
G. W. Grimeet al. (1985)Trends Biochem. Sci. 10, 6–10.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vaux, D.J.T., Grime, G.W. & Watt, F. Some medical applications of the oxford scanning proton microprobe. Biol Trace Elem Res 13, 115–133 (1987). https://doi.org/10.1007/BF02796626
Issue Date:
DOI: https://doi.org/10.1007/BF02796626